Models:
Joseph Gordon
joseph-gordon/
ClinicalAttritionRatePred
0
Downloads: 1
[6e0d8e]: / updated_clinical_attrition.csv

Download this file

# nct_id dropout_percentage_all Clinical Title Overall Status Trial Phase Allocation Start Date Completion Date Primary Purpose City State Zipcode Gender Minimum Age Maximum Age New Completion Date New Start Date length_of_trial
1 NCT00001596 17.39130435 Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome Completed Phase 2 Randomized September 2005 May 9, 2016 Treatment Bethesda Maryland 20892 All 18 Years 2016-05-01 2005-09-01 3895.0
2 NCT00001723 8.0 Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases Completed Phase 2 Randomized May 1998 October 2011 Treatment Bethesda Maryland 20892 All 12 Years 17 Years 2011-10-01 1998-05-01 4901.0
3 NCT00003869 21.87789084 Carboxyamidotriazole in Treating Patients With Stage III or Stage IV Non-small Cell Lung Cancer Completed Phase 3 Randomized April 1999 May 2008 Treatment Rochester Minnesota 55905 All 18 Years 2008-05-01 1999-04-01 3318.0
4 NCT00003901 0.8595988539 Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery Completed Phase 3 July 1999 October 2011 Diagnostic Mobile Alabama 36608 All 18 Years 2011-10-01 1999-07-01 4475.0
5 NCT00045162 24.43651603 S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer Completed Phase 3 Randomized November 2002 December 2009 Treatment Anniston Alabama 36202 All 18 Years 120 Years 2009-12-01 2002-11-01 2587.0
6 NCT00047385 1.406735931 National Lung Screening Trial (NLST) Screening Completed Phase 3 Randomized August 2002 October 2010 Screening Birmingham Alabama 35233 All 55 Years 74 Years 2010-10-01 2002-08-01 2983.0
7 NCT00047463 13.63636364 Effects of Treating Obstructive Sleep Apnea in Epilepsy Completed Phase 2 Randomized September 2002 July 2008 Treatment Ann Arbor Michigan 48109 All 18 Years 2008-07-01 2002-09-01 2130.0
8 NCT00048997 7.975460123 Radiation Therapy in Preventing Central Nervous System (CNS) Metastases in Patients With Non-Small Cell Lung Cancer Completed Phase 3 Randomized September 2002 December 2016 Treatment Phoenix Arizona 85013 All 18 Years 2016-12-01 2002-09-01 5205.0
9 NCT00049543 0.0 Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery Completed Phase 3 Randomized September 2002 April 2011 Treatment Kingston Ontario K7L 3N6 All 18 Years 2011-04-01 2002-09-01 3134.0
10 NCT00050960 40.19607843 Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer Completed Phase 3 Randomized May 2002 March 2005 Treatment Montgomery Alabama 36106 All 2005-03-01 2002-05-01 1035.0
11 NCT00051363 22.62039077 Apnea Positive Pressure Long-Term Efficacy Study Completed Phase 3 Randomized September 2002 September 2008 Treatment Tucson Arizona 85724 All 18 Years 2008-09-01 2002-09-01 2192.0
12 NCT00053846 12.92056595 Buspirone in Reducing Shortness of Breath in Patients With Cancer Completed Phase 2/Phase 3 Randomized November 2002 January 2011 Supportive Care Chicago Illinois 60612-7323 All 18 Years 120 Years 2011-01-01 2002-11-01 2983.0
13 NCT00057746 0.5050505051 Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer Completed Phase 2 Randomized February 2003 November 2013 Treatment Birmingham Alabama 35294 All 120 Years 2013-11-01 2003-02-01 3926.0
14 NCT00057837 20.45454545 Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Extensive-Stage Small Cell Lung Cancer Completed Phase 2 Randomized July 14, 2004 August 2012 Treatment Lewes Delaware 19958 All 18 Years 2012-08-01 2004-07-01 2953.0
15 NCT00062010 0.0 Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer Completed Phase 2 May 26, 2004 August 2012 Treatment Decatur Georgia 30033 All 18 Years 2012-08-01 2004-05-01 3014.0
16 NCT00063154 25.58139535 Safety and Effect of Pertuzumab in Patients With Advanced Non-Small Cell Lung Cancer, Which Has Progressed After Prior Chemotherapy Completed Phase 2 July 2003 April 2005 Treatment Scottsdale Arizona 85258 All 18 Years 2005-04-01 2003-07-01 640.0
17 NCT00065429 4.87804878 Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer Completed Phase 1/Phase 2 Non-Randomized April 2003 December 2008 Treatment Denver Colorado 80218 All 18 Years 2008-12-01 2003-04-01 2071.0
18 NCT00066222 1.408450704 Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer Completed Phase 2 June 2003 November 2013 Treatment Birmingham Alabama 35294 All 18 Years 2013-11-01 2003-06-01 3806.0
19 NCT00069823 2.246453945 Study of Acid Reflux in Asthma Completed Phase 3 Randomized September 2003 May 2008 Treatment Birmingham Alabama 35294 All 18 Years 2008-05-01 2003-09-01 1704.0
20 NCT00071032 0.8433040077 Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular Disease Completed Phase 3 Randomized July 2003 May 2009 Treatment New Brunswick New Jersey 08903 All 50 Years 2009-05-01 2003-07-01 2131.0
21 NCT00078312 46.64634146 Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder Completed Phase 3 Non-Randomized January 2004 July 2006 Treatment Peoria Arizona 85381 All 18 Years 65 Years 2006-07-01 2004-01-01 912.0
22 NCT00079040 1.587301587 Cisplatin, Etoposide, and Bevacizumab in Treating Patients With Previously Untreated Extensive Stage Small Cell Lung Cancer Completed Phase 2 January 2006 January 2009 Treatment Boston Massachusetts 02215 All 18 Years 2009-01-01 2006-01-01 1096.0
23 NCT00079937 14.96609178 Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma Completed Phase 3 Randomized April 2004 March 2008 Treatment Birmingham Alabama 35209 All 6 Years 11 Years 2008-03-01 2004-04-01 1430.0
24 NCT00080223 54.21686747 Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis Completed Phase 2 August 31, 2003 April 30, 2015 Other Phoenix Arizona 85006 All 40 Years 85 Years 2015-04-01 2003-08-01 4261.0
25 NCT00080938 52.38095238 Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer Completed Phase 2 December 20, 2005 February 2009 Treatment All 18 Years 2009-02-01 2005-12-01 1158.0
26 NCT00087438 0.0 Stereotactic Body Radiation Therapy in Treating Patients With Inoperable Stage I or Stage II Non-Small Cell Lung Cancer Completed Phase 2 May 2004 December 2016 Treatment Rochester New York 14642 All 18 Years 2016-12-01 2004-05-01 4597.0
27 NCT00087698 18.18181818 Phase II Trial of Neo-Adjuvant Pemetrexed Plus Cisplatin Followed by Surgery and Radiation for Pleural Mesothelioma Completed Phase 2 Non-Randomized September 2003 February 2008 Treatment San Francisco California All 18 Years 2008-02-01 2003-09-01 1614.0
28 NCT00090142 7.258064516 Montelukast in Exercise-Induced Bronchospasm - 2004 (0476-275) Completed Phase 3 Randomized May 2004 October 2004 Prevention All 15 Years 45 Years 2004-10-01 2004-05-01 153.0
29 NCT00092118 7.378878606 The Clinical Effects of Montelukast in Patients With Perennial Allergic Rhinitis (0476-265) Completed Phase 3 Randomized October 2003 May 2004 Treatment All 15 Years 85 Years 2004-05-01 2003-10-01 213.0
30 NCT00092131 1.960784314 Montelukast in Exercise-Induced Bronchospasm - 2003 (0476-270) Completed Phase 3 Randomized June 2003 November 2003 Prevention All 15 Years 45 Years 2003-11-01 2003-06-01 153.0
31 NCT00094094 21.875 Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer Completed Phase 2 February 2005 July 2007 Treatment Irvine California 92612 All 18 Years 2007-07-01 2005-02-01 880.0
32 NCT00094861 20.25288376 Study to Evaluate Palifermin in the Reduction of Dysphagia in Patients With Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Completed Phase 2 Randomized January 2005 January 2014 Treatment All 18 Years 2014-01-01 2005-01-01 3287.0
33 NCT00095199 18.6503884 Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer Completed Phase 3 Randomized January 2005 July 2011 Treatment Birmingham Alabama 35294 All 18 Years 2011-07-01 2005-01-01 2372.0
34 NCT00096226 26.31578947 Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer Completed Phase 2 September 2004 May 16, 2016 Treatment Phoenix Arizona 85013 All 18 Years 2016-05-01 2004-09-01 4260.0
35 NCT00096486 6.477732794 Gefitinib and Everolimus in Treating Patients With Stage IIIB or Stage IV or Recurrent Non-Small Cell Lung Cancer Completed Phase 1/Phase 2 May 2004 July 2010 Treatment New York New York 10021 All 18 Years 120 Years 2010-07-01 2004-05-01 2252.0
36 NCT00097773 6.25 Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis Completed Phase 2 Randomized September 2004 August 2009 Prevention Birmingham Alabama 35233 All 1 Year 12 Years 2009-08-01 2004-09-01 1795.0
37 NCT00098254 5.405405405 BAY 43-9006 (Sorafenib) to Treat Relapsed Non-Small Cell Lung Cancer Completed Phase 2 Non-Randomized December 2004 January 2011 Treatment Bethesda Maryland 20892 All 18 Years 2011-01-01 2004-12-01 2222.0
38 NCT00100932 21.97802198 Phase II Study Of E7389, Halichondrin B Analogue, In Patients With Advanced Non-Small Cell Lung Cancer, NSCLC, Who Progressed During Or After Platinum-Based Doublet Chemotherapy Completed Phase 2 Non-Randomized December 2004 Treatment Gilroy California All 18 Years 2004-12-01
39 NCT00102804 12.79340565 Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer (NSCLC) Completed Phase 3 Randomized March 2005 December 2013 Treatment Minneapolis Minnesota 55455 All 18 Years 2013-12-01 2005-03-01 3197.0
40 NCT00103259 13.95881007 Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Completed Phase 2 Randomized July 2005 November 2011 Treatment Boston Massachusetts 02215 All 18 Years 2011-11-01 2005-07-01 2314.0
41 NCT00104520 52.59259259 Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa Completed Phase 3 Randomized February 2005 September 2006 Treatment Phoenix Arizona All 6 Years 2006-09-01 2005-02-01 577.0
42 NCT00105183 5.188943886 EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft Rejection Completed Phase 3 Randomized January 2005 January 2011 Prevention Los Angeles California 90048 All 18 Years 2011-01-01 2005-01-01 2191.0
43 NCT00107952 5.361968834 Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus Completed Phase 3 Randomized February 2005 July 2007 Treatment Springfield Massachusetts 01199 All 18 Years 2007-07-01 2005-02-01 880.0
44 NCT00111839 26.26866917 Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer Completed Phase 2 Randomized May 31, 2005 March 31, 2009 Treatment Tucson Arizona 85715 All 18 Years 2009-03-01 2005-05-01 1400.0
45 NCT00112294 0.0 Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer Completed Phase 3 Randomized December 2004 August 2008 Treatment Birmingham Alabama All 18 Years 2008-08-01 2004-12-01 1339.0
46 NCT00112359 24.19642857 International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa Completed Phase 3 Randomized May 2005 April 2007 Treatment Birmingham Alabama All 6 Years 2007-04-01 2005-05-01 700.0
47 NCT00113516 26.19047619 A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer Completed Phase 2 Non-Randomized September 2005 March 2009 Treatment Los Angeles California 90048 All 18 Years 2009-03-01 2005-09-01 1277.0
48 NCT00117325 6.25181645 Study Of Adults And Adolescents With Vasomotor Rhinitis Completed Phase 3 Randomized July 11, 2005 February 9, 2006 Treatment Beverly Hills California 90212 All 12 Years 2006-02-01 2005-07-01 215.0
49 NCT00117338 2.524348513 A Study of an Intravenous Drug in Pediatric Patients With Acute Asthma (0476-301) Completed Phase 3 Randomized July 2005 March 2008 Treatment All 6 Years 14 Years 2008-03-01 2005-07-01 974.0
50 NCT00117572 4.396135266 Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE) Completed Phase 3 Randomized November 2004 December 2016 Treatment Los Angeles California 90033 All 18 Years 2016-12-01 2004-11-01 4413.0
51 NCT00118703 4.031293602 Once-Daily Investigational Nasal Spray In Adults And Adolescents With Vasomotor Rhinitis Completed Phase 3 Randomized July 1, 2005 February 9, 2006 Treatment Birmingham Alabama 35209 All 12 Years 2006-02-01 2005-07-01 215.0
52 NCT00124020 5.416724836 Comparison of Telavancin and Vancomycin for Hospital-acquired Pneumonia Due to Methicillin-resistant Staphylococcus Aureus Completed Phase 3 Randomized January 2005 May 2007 Treatment Tel Hashomer 52621 All 18 Years 2007-05-01 2005-01-01 850.0
53 NCT00124618 0.0 Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer Completed Phase 2 January 2006 March 2015 Treatment Scottsdale Arizona 85259-5499 All 18 Years 2015-03-01 2006-01-01 3346.0
54 NCT00125359 11.9047619 Study of Tarceva and Targretin Oral Capsules in Patients With Advanced Lung Cancer Completed Phase 2 August 2005 March 2014 Treatment Lebanon New Hampshire 03756 All 18 Years 2014-03-01 2005-08-01 3134.0
55 NCT00127166 4.520917679 Two Investigational Drugs in the Prevention of Airway Constriction Brought on by Exercise in Participants With Asthma (0476-911) Completed Phase 3 Randomized December 2005 November 2008 Treatment All 6 Years 14 Years 2008-11-01 2005-12-01 1066.0
56 NCT00127855 2.207317073 Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine Completed Phase 2 Randomized March 1, 2003 February 12, 2004 Prevention North Adelaide South Australia 5006 All 6 Weeks 12 Weeks 2004-02-01 2003-03-01 337.0
57 NCT00128492 25.13849984 Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis (CF) Patients With Pseudomonas Aeruginosa (PA) Completed Phase 3 Non-Randomized August 2005 January 2009 Treatment Birmingham Alabama All 6 Years 2009-01-01 2005-08-01 1249.0
58 NCT00129116 3.096903097 3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age Completed Phase 2 Randomized March 1, 2003 December 16, 2003 Prevention Asse Bayern 1730 All 6 Weeks 12 Weeks 2003-12-01 2003-03-01 275.0
59 NCT00129766 1.62806476 Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children Completed Phase 3 Randomized November 2004 May 2006 Prevention Birmingham Alabama 35233 All 24 Months 2006-05-01 2004-11-01 546.0
60 NCT00138658 34.56790123 A Study of OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) Completed Phase 1/Phase 2 November 2004 March 2010 Treatment Los Angeles California 90033 All 18 Years 2010-03-01 2004-11-01 1946.0
61 NCT00139659 19.38453318 A One Year Clinical Trial Assessing the Usefulness and Safety of Inhaled Insulin in Diabetics With Asthma Completed Phase 3 Randomized January 2003 October 2008 Treatment Glendale Arizona 85306 All 18 Years 77 Years 2008-10-01 2003-01-01 2100.0
62 NCT00143455 26.38508416 Study Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer Completed Phase 3 Randomized June 2002 December 2008 Treatment Wels A-4600 All 18 Years 75 Years 2008-12-01 2002-06-01 2375.0
63 NCT00144339 40.99070223 Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients Completed Phase 3 December 2002 Treatment Anniston Alabama All 40 Years 2002-12-01
64 NCT00147537 41.98247536 Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer Completed Phase 1/Phase 2 Randomized February 2005 August 2011 Treatment Tucson Arizona 85719 All 18 Years 2011-08-01 2005-02-01 2372.0
65 NCT00157196 0.0 Safety Study of Tecemotide (L-BLP25) in Non-Small Cell Lung Cancer (NSCLC) Subjects With Unresectable Stage III Disease Completed Phase 2 April 2005 April 2012 Treatment All 18 Years 2012-04-01 2005-04-01 2557.0
66 NCT00157209 0.0 Phase 2b Randomized Controlled Study of Tecemotide (L-BLP25) for Immunotherapy of NSCLC (Non-Small Cell Lung Cancer) Completed Phase 2 Randomized August 2000 July 2012 Treatment Darmstadt All 18 Years 2012-07-01 2000-08-01 4352.0
67 NCT00159822 35.41666667 Voriconazole For Chronic Bronchopulmonary Aspergillosis Completed Phase 2/Phase 3 Non-Randomized July 2005 December 2008 Treatment Nantes Cedex 44093 All 18 Years 2008-12-01 2005-07-01 1249.0
68 NCT00159913 2.673160173 A Randomized, Double-Blind, Placebo-Controlled Study of Sildenafil in Children With Pulmonary Arterial Hypertension. Completed Phase 3 Randomized August 2003 June 2008 Treatment Palo Alto California 94304 All 1 Year 17 Years 2008-06-01 2003-08-01 1766.0
69 NCT00168831 25.35410676 Tiotropium / Respimat One-Year Study Completed Phase 3 Randomized February 2003 Treatment Birmingham Alabama All 40 Years 2003-02-01
70 NCT00168844 20.55305863 Tiotropium / Respimat One-Year Study Completed Phase 3 Randomized January 2003 Treatment Los Angeles California All 40 Years 2003-01-01
71 NCT00171834 45.71428571 Dose Escalating Study of the Safety and Efficacy of Patupilone, q3w, in Patients With Non-small Cell Lung Cancer Completed Phase 1/Phase 2 Non-Randomized August 2003 September 2008 Treatment Louisville Kentucky 40232-5070 All 18 Years 2008-09-01 2003-08-01 1858.0
72 NCT00172042 33.68703603 A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer (NSCLC) Completed Phase 3 Randomized March 2005 June 2010 Prevention Jette All 18 Years 2010-06-01 2005-03-01 1918.0
73 NCT00182689 32.25146199 Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer Completed Phase 2 July 2005 October 2008 Treatment Portland Oregon 97239 All 18 Years 2008-10-01 2005-07-01 1188.0
74 NCT00191139 21.875 Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer (NSCLC) Completed Phase 2 Randomized March 2003 February 2009 Treatment Denver Colorado 80218 All 18 Years 2009-02-01 2003-03-01 2164.0
75 NCT00191191 28.24074074 To Investigate Efficacy and Safety of Pemetrexed as Second or Third Line Therapy in Patients With Non-small Cell Lung Cancer (NSCLC) Completed Phase 2 Randomized October 2004 October 2008 Treatment Chiba All 20 Years 75 Years 2008-10-01 2004-10-01 1461.0
76 NCT00191308 3.333333333 Molecular Profiling in Lung Cancer Patients Completed Phase 2 Non-Randomized May 2005 December 2010 Treatment Bystra Slaska 43-360 All 18 Years 2010-12-01 2005-05-01 2040.0
77 NCT00192036 28.57142857 Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer Completed Phase 2 Non-Randomized August 2004 November 2009 Treatment Aalst 9300 All 18 Years 2009-11-01 2004-08-01 1918.0
78 NCT00197106 3.75 Treatment Of Symptomatic Asthma In Children Completed Phase 4 Randomized June 2005 October 2008 Treatment Almere 1315 RA All 6 Years 12 Years 2008-10-01 2005-06-01 1218.0
79 NCT00200967 13.96825397 Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE) Completed Phase 3 Randomized December 2004 February 2008 Treatment San Diego California 92103 All 18 Years 90 Years 2008-02-01 2004-12-01 1157.0
80 NCT00207740 23.05019542 A Study of Safety and Efficacy of CNTO 148 in Patients With Severe Persistent Asthma Completed Phase 2 Randomized August 2004 July 2007 Treatment Los Angeles California All 18 Years 2007-07-01 2004-08-01 1064.0
81 NCT00216203 6.060606061 Pemetrexed Plus Cetuximab in Patients With Recurrent Non Small Cell Lung Cancer Completed Phase 1/Phase 2 May 2005 December 2008 Treatment Galesburg Illinois 61401 All 18 Years 2008-12-01 2005-05-01 1310.0
82 NCT00227539 4.0 Positron Emission Tomography in Predicting Response in Patients Who Are Undergoing Treatment With Pemetrexed Disodium and Cisplatin With or Without Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer Completed Phase 2 July 2005 November 2013 Treatment Seattle Washington 98109-1023 All 18 Years 120 Years 2013-11-01 2005-07-01 3045.0
83 NCT00228553 47.60601915 Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness Completed Phase 3 Non-Randomized May 2004 July 2006 Treatment Birmingham Alabama 35213 All 18 Years 65 Years 2006-07-01 2004-05-01 791.0
84 NCT00228566 21.05263158 Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome Completed Phase 3 Non-Randomized October 2005 July 2006 Treatment Birmingham Alabama 35213 All 18 Years 65 Years 2006-07-01 2005-10-01 273.0
85 NCT00231465 4.545454545 Phase II Study of Docetaxel + ZD1839 in Elderly Patients With Non-Small Cell Lung Cancer Completed Phase 2 July 2003 August 2012 Treatment Tampa Florida 33612 All 70 Years 2012-08-01 2003-07-01 3319.0
86 NCT00232557 5.958829902 Telecommunications System in Asthma Completed Phase 3 Randomized August 2004 December 2009 Boston Massachusetts 02130 All 18 Years 2009-12-01 2004-08-01 1948.0
87 NCT00243074 21.27659574 S0509 - AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By Surgery Completed Phase 2 November 2005 December 2011 Treatment San Antonio Texas 78245 All 18 Years 2011-12-01 2005-11-01 2221.0
88 NCT00244725 7.650205539 Odiparcil For The Prevention Of Venous Thromboembolism Completed Phase 2 Randomized September 2005 September 2006 Prevention Birmingham Alabama 35209 All 35 Years 2006-09-01 2005-09-01 365.0
89 NCT00245570 0.3546099291 Montelukast Compared With Placebo and Salmeterol in Exercise-Induced Bronchoconstriction (0476-316) Completed Phase 3 Randomized December 2005 September 2006 Prevention All 15 Years 45 Years 2006-09-01 2005-12-01 274.0
90 NCT00247416 5.225806452 Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer Completed Phase 2 Randomized August 2005 July 2009 Treatment Danville Kentucky 40422 All 18 Years 2009-07-01 2005-08-01 1430.0
91 NCT00248495 2.631578947 Pemetrexed Disodium and Cisplatin in Treating Patients Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer Completed Phase 2 June 8, 2005 April 5, 2017 Treatment Buffalo New York 14263-0001 All 18 Years 120 Years 2017-04-01 2005-06-01 4322.0
92 NCT00250679 27.30371791 Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease Completed Phase 3 Randomized October 2005 October 2007 Treatment Birmingham Alabama 33744 All 35 Years 2007-10-01 2005-10-01 730.0
93 NCT00254566 8.838383838 A Trial To Evaluate Two Antibiotics For The Treatment Of Acute Exacerbation Of Chronic Bronchitis (AECB) Completed Phase 3 Randomized February 2006 August 2008 Treatment Guangzhou Guangdong 510080 All 50 Years 2008-08-01 2006-02-01 912.0
94 NCT00255047 8.861391361 Safety and Immune Response of Different Pediatric Combination Vaccines. Completed Phase 3 Randomized November 2005 February 2009 Prevention Tuscaloosa Alabama 35401 All 42 Days 89 Days 2009-02-01 2005-11-01 1188.0
95 NCT00257608 14.27432795 A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS) Completed Phase 3 Randomized January 2006 November 2014 Treatment Mobile Alabama 36608 All 18 Years 2014-11-01 2006-01-01 3226.0
96 NCT00258895 1.952619971 Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL® Completed Phase 3 Non-Randomized March 2005 April 2007 Prevention Fayetteville Arkansas 15213 All 4 Years 6 Years 2007-04-01 2005-03-01 761.0
97 NCT00261833 11.80941787 Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor Deficiency Completed Phase 4 Randomized March 2006 September 2012 Treatment Denver Colorado 80206 All 18 Years 65 Years 2012-09-01 2006-03-01 2376.0
98 NCT00263887 6.477732794 Alpha-1-Antitrypsin (AAT) To Treat Emphysema In AAT-Deficient Patients (EXACTLE) Completed Phase 2 Randomized December 2003 January 2007 Treatment Hellerup England 2900 All 18 Years 2007-01-01 2003-12-01 1127.0
99 NCT00264576 0.3262720886 Study of the Safety and Immunogenicity of an Influenza Vaccine Administered to Healthy Adults Completed Phase 2 Randomized October 2005 May 2006 Prevention Bardstown Kentucky 40004 All 18 Years 49 Years 2006-05-01 2005-10-01 212.0
100 NCT00264849 10.89154412 Omalizumab in Adult and Adolescent Patients With Severe Persistent Allergic Asthma Completed Phase 4 Randomized November 2005 September 2008 Treatment Bruxelles All 12 Years 75 Years 2008-09-01 2005-11-01 1035.0